BioPharmSignal logoBioPharmSignal

Biotech News

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

PTC Therapeutics, Inc. (PTCT)PTC Therapeutics, Inc.Earnings

WARREN, N.J., April 22, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, May 7, 2026, at 4:30

Open original release

Related news

PTCTPTC Therapeutics, Inc.2026-05-07 20:01 EST

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTCTPTC Therapeutics, Inc.2026-02-19 21:01 EST

PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

CAPRCapricor Therapeutics2026-05-04 20:05 EST

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

MNPRMonopar2026-05-14 18:00 EST

Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

TARAProtara Therapeutics2026-05-13 12:00 EST

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

CAPRCapricor Therapeutics2026-05-12 20:05 EST

Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

ABEOAbeona Therapeutics2026-05-04 12:30 EST

Abeona Therapeutics® Announces Date of First Quarter Financial Results

KRYSKrystal Biotech2026-04-21 12:00 EST

Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

BCRXBioCryst Pharmaceuticals2026-04-15 11:00 EST

BioCryst to Report First Quarter 2026 Financial Results on May 6

CRNXCrinetics Pharmaceuticals2026-04-08 20:05 EST

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

View all latest news

PTC Therapeutics, Inc.

PTC Therapeutics is a biopharmaceutical company focused on rare disease and gene-related therapies. Its story combines commercial products with a pipeline aimed at genetically defined conditions.

Recent company news

PTCTPTC Therapeutics, Inc.2026-05-07 20:01 EST

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTCTPTC Therapeutics, Inc.2026-05-04 12:00 EST

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTCTPTC Therapeutics, Inc.2026-04-28 20:05 EST

PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

PTCTPTC Therapeutics, Inc.2026-04-28 13:28 EST

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

PTCTPTC Therapeutics, Inc.2026-04-22 12:00 EST

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Stock data

Close
75.80 USD
Market cap
5.66B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States